Pressmeddelanden
Coegin Pharma provides an operational and strategic update
Coegin Pharma AB ("Coegin" or the "Company") today provides an operational and strategic update regarding its commercialization activities and business planning.
Operational upda...
Coegin Pharma appoints worldleading pigmentation and hair-biology expert Professor Desmond J. Tobin as Scientific Advisor
Coegin Pharma AB ("Coegin") is delighted to announce that Professor Desmond J. Tobin, a globally recognized leader in skin and hair pigmentation science and hair-follicle biology...
Coegin Pharma completes first delivery of Follicopeptide products to Hårklinikken
Coegin Pharma AB ("Coegin" or the "Company") today announces that the Company has completed its first commercial delivery of hair growth products based on Follicopeptide® to Hårk...
Coegin Pharma delivers first commercial batch of Follicopeptide products to Gents
Coegin Pharma AB ("Coegin" or the "Company") today announces that the Company has successfully produced and delivered its first commercial batch of hair growth products based on...
REG
Coegin Pharma's Nomination Committee appointed for the 2026 Annual General Meeting
The Nomination Committee of Coegin Pharma has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on May 22, 2025....
REG
Coegin Pharma AB (publ) publishes its quarterly report for the third quarter of 2025
Summary of interim reportThe third quarter of 2025 marks a historic turning point for Coegin Pharma. The company has successfully transitioned from a development-focused biotech...
Rapporter
Video
Finansiell kalender
Bokslutskommuniké 2025
Bokslutskommuniké
Om Coegin Pharma
Coegin Pharma är ett svenskt bioteknikföretag som utvecklar banbrytande innovationer för hår och hud.
Webbplats
www.coeginpharma.com
Bransch
Bioteknik
Prenumerera
Få löpande information från Coegin Pharma via e-post.
Handelsinformation
Kurs 4,31 SEK (2026-01-23)
Förändring 1,41% (2025-01-23)